UniProt ID | ESYT1_HUMAN | |
---|---|---|
UniProt AC | Q9BSJ8 | |
Protein Name | Extended synaptotagmin-1 | |
Gene Name | ESYT1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1104 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein. Cell membrane Peripheral membrane protein. Localizes primarily to the endoplasmic reticulum. Recruited to sites of contact between the endoplasmic reticulum and the cell membrane in respon |
|
Protein Description | Binds glycerophospholipids in a barrel-like domain and may play a role in cellular lipid transport (By similarity). Binds calcium (via the C2 domains) and translocates to sites of contact between the endoplasmic reticulum and the cell membrane in response to increased cytosolic calcium levels. Helps tether the endoplasmic reticulum to the cell membrane and promotes the formation of appositions between the endoplasmic reticulum and the cell membrane.. | |
Protein Sequence | MERSPGEGPSPSPMDQPSAPSDPTDQPPAAHAKPDPGSGGQPAGPGAAGEALAVLTSFGRRLLVLIPVYLAGAVGLSVGFVLFGLALYLGWRRVRDEKERSLRAARQLLDDEEQLTAKTLYMSHRELPAWVSFPDVEKAEWLNKIVAQVWPFLGQYMEKLLAETVAPAVRGSNPHLQTFTFTRVELGEKPLRIIGVKVHPGQRKEQILLDLNISYVGDVQIDVEVKKYFCKAGVKGMQLHGVLRVILEPLIGDLPFVGAVSMFFIRRPTLDINWTGMTNLLDIPGLSSLSDTMIMDSIAAFLVLPNRLLVPLVPDLQDVAQLRSPLPRGIIRIHLLAARGLSSKDKYVKGLIEGKSDPYALVRLGTQTFCSRVIDEELNPQWGETYEVMVHEVPGQEIEVEVFDKDPDKDDFLGRMKLDVGKVLQASVLDDWFPLQGGQGQVHLRLEWLSLLSDAEKLEQVLQWNWGVSSRPDPPSAAILVVYLDRAQDLPLKKGNKEPNPMVQLSIQDVTQESKAVYSTNCPVWEEAFRFFLQDPQSQELDVQVKDDSRALTLGALTLPLARLLTAPELILDQWFQLSSSGPNSRLYMKLVMRILYLDSSEICFPTVPGCPGAWDVDSENPQRGSSVDAPPRPCHTTPDSQFGTEHVLRIHVLEAQDLIAKDRFLGGLVKGKSDPYVKLKLAGRSFRSHVVREDLNPRWNEVFEVIVTSVPGQELEVEVFDKDLDKDDFLGRCKVRLTTVLNSGFLDEWLTLEDVPSGRLHLRLERLTPRPTAAELEEVLQVNSLIQTQKSAELAAALLSIYMERAEDLPLRKGTKHLSPYATLTVGDSSHKTKTISQTSAPVWDESASFLIRKPHTESLELQVRGEGTGVLGSLSLPLSELLVADQLCLDRWFTLSSGQGQVLLRAQLGILVSQHSGVEAHSHSYSHSSSSLSEEPELSGGPPHITSSAPELRQRLTHVDSPLEAPAGPLGQVKLTLWYYSEERKLVSIVHGCRSLRQNGRDPPDPYVSLLLLPDKNRGTKRRTSQKKRTLSPEFNERFEWELPLDEAQRRKLDVSVKSNSSFMSRERELLGKVQLDLAETDLSQGVARWYDLMDNKDKGSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MERSPGEG -------CCCCCCCC | 42.26 | 19413330 | |
4 | Phosphorylation | ----MERSPGEGPSP ----CCCCCCCCCCC | 40.31 | 23663014 | |
10 | Phosphorylation | RSPGEGPSPSPMDQP CCCCCCCCCCCCCCC | 49.19 | 23663014 | |
12 | Phosphorylation | PGEGPSPSPMDQPSA CCCCCCCCCCCCCCC | 36.87 | 23663014 | |
18 | Phosphorylation | PSPMDQPSAPSDPTD CCCCCCCCCCCCCCC | 47.37 | 23312004 | |
24 | O-linked_Glycosylation | PSAPSDPTDQPPAAH CCCCCCCCCCCCCCC | 52.86 | OGP | |
77 | Phosphorylation | LAGAVGLSVGFVLFG HHHHHHHHHHHHHHH | 17.79 | - | |
88 | Phosphorylation | VLFGLALYLGWRRVR HHHHHHHHHCHHHHH | 9.50 | 30576142 | |
116 | Phosphorylation | LDDEEQLTAKTLYMS CCCHHHHHHHHHHHH | 26.29 | 28857561 | |
118 | Ubiquitination | DEEQLTAKTLYMSHR CHHHHHHHHHHHHHC | 33.55 | 21890473 | |
118 (in isoform 2) | Ubiquitination | - | 33.55 | 21890473 | |
118 (in isoform 1) | Ubiquitination | - | 33.55 | 21890473 | |
119 | Phosphorylation | EEQLTAKTLYMSHRE HHHHHHHHHHHHHCC | 22.21 | 23090842 | |
121 | Phosphorylation | QLTAKTLYMSHRELP HHHHHHHHHHHCCCC | 11.21 | 25884760 | |
123 | Phosphorylation | TAKTLYMSHRELPAW HHHHHHHHHCCCCCC | 13.06 | 23090842 | |
132 | Phosphorylation | RELPAWVSFPDVEKA CCCCCCCCCCCHHHH | 21.99 | 28857561 | |
138 | Ubiquitination | VSFPDVEKAEWLNKI CCCCCHHHHHHHHHH | 51.99 | 21890473 | |
138 (in isoform 2) | Ubiquitination | - | 51.99 | 21890473 | |
138 | Acetylation | VSFPDVEKAEWLNKI CCCCCHHHHHHHHHH | 51.99 | 26822725 | |
138 (in isoform 1) | Ubiquitination | - | 51.99 | 21890473 | |
170 | Methylation | ETVAPAVRGSNPHLQ HHHHHHHCCCCCCCE | 44.95 | - | |
172 | Phosphorylation | VAPAVRGSNPHLQTF HHHHHCCCCCCCEEE | 36.30 | 29978859 | |
178 | Phosphorylation | GSNPHLQTFTFTRVE CCCCCCEEEEEEEEE | 30.88 | 27067055 | |
180 | Phosphorylation | NPHLQTFTFTRVELG CCCCEEEEEEEEEEC | 27.73 | 27067055 | |
182 | Phosphorylation | HLQTFTFTRVELGEK CCEEEEEEEEEECCC | 30.65 | 27067055 | |
189 | Acetylation | TRVELGEKPLRIIGV EEEEECCCCEEEEEE | 47.78 | 23749302 | |
189 | Ubiquitination | TRVELGEKPLRIIGV EEEEECCCCEEEEEE | 47.78 | 1890473 | |
189 (in isoform 2) | Ubiquitination | - | 47.78 | 21890473 | |
189 (in isoform 1) | Ubiquitination | - | 47.78 | 21890473 | |
197 | Ubiquitination | PLRIIGVKVHPGQRK CEEEEEEEECCCCCH | 29.61 | 21890473 | |
197 (in isoform 2) | Ubiquitination | - | 29.61 | 21890473 | |
197 | Malonylation | PLRIIGVKVHPGQRK CEEEEEEEECCCCCH | 29.61 | 26320211 | |
197 | Acetylation | PLRIIGVKVHPGQRK CEEEEEEEECCCCCH | 29.61 | 25953088 | |
197 (in isoform 1) | Ubiquitination | - | 29.61 | 21890473 | |
231 | Ubiquitination | EVKKYFCKAGVKGMQ EHHHHHHHHCCCHHC | 37.97 | - | |
235 | Malonylation | YFCKAGVKGMQLHGV HHHHHCCCHHCHHHH | 47.98 | 26320211 | |
269 | Phosphorylation | MFFIRRPTLDINWTG EEEECCCCCCCCCCC | 34.94 | - | |
324 | Phosphorylation | QDVAQLRSPLPRGII HHHHHHCCCCCCHHH | 39.10 | 25849741 | |
344 | Ubiquitination | AARGLSSKDKYVKGL HHCCCCCCCHHHHHH | 55.66 | - | |
347 | Phosphorylation | GLSSKDKYVKGLIEG CCCCCCHHHHHHCCC | 19.96 | 29978859 | |
349 | Ubiquitination | SSKDKYVKGLIEGKS CCCCHHHHHHCCCCC | 44.93 | - | |
349 (in isoform 2) | Ubiquitination | - | 44.93 | - | |
355 | Ubiquitination | VKGLIEGKSDPYALV HHHHCCCCCCCCHHH | 38.61 | 21906983 | |
355 (in isoform 2) | Ubiquitination | - | 38.61 | 21890473 | |
355 | Malonylation | VKGLIEGKSDPYALV HHHHCCCCCCCCHHH | 38.61 | 32601280 | |
355 (in isoform 1) | Ubiquitination | - | 38.61 | 21890473 | |
356 | Phosphorylation | KGLIEGKSDPYALVR HHHCCCCCCCCHHHE | 55.46 | 20860994 | |
359 | Phosphorylation | IEGKSDPYALVRLGT CCCCCCCCHHHEECC | 19.98 | 25884760 | |
366 | Phosphorylation | YALVRLGTQTFCSRV CHHHEECCCCHHHHH | 29.09 | 26471730 | |
371 | Phosphorylation | LGTQTFCSRVIDEEL ECCCCHHHHHCCCCC | 25.95 | 26471730 | |
409 | Ubiquitination | VFDKDPDKDDFLGRM EECCCCCCCCCCCCC | 65.66 | - | |
417 | Ubiquitination | DDFLGRMKLDVGKVL CCCCCCCCCCHHHHH | 39.93 | - | |
417 | Acetylation | DDFLGRMKLDVGKVL CCCCCCCCCCHHHHH | 39.93 | 25953088 | |
422 | Ubiquitination | RMKLDVGKVLQASVL CCCCCHHHHHHHHEE | 39.35 | - | |
422 (in isoform 2) | Ubiquitination | - | 39.35 | - | |
453 | Phosphorylation | LEWLSLLSDAEKLEQ HHHHHHHCCHHHHHH | 39.82 | - | |
493 | Ubiquitination | RAQDLPLKKGNKEPN HHHCCCCCCCCCCCC | 57.61 | - | |
493 | Malonylation | RAQDLPLKKGNKEPN HHHCCCCCCCCCCCC | 57.61 | 26320211 | |
493 | Acetylation | RAQDLPLKKGNKEPN HHHCCCCCCCCCCCC | 57.61 | 25953088 | |
494 (in isoform 2) | Phosphorylation | - | 75.33 | - | |
495 (in isoform 2) | Phosphorylation | - | 49.18 | - | |
497 | Ubiquitination | LPLKKGNKEPNPMVQ CCCCCCCCCCCCCEE | 81.08 | - | |
497 | Malonylation | LPLKKGNKEPNPMVQ CCCCCCCCCCCCCEE | 81.08 | 26320211 | |
497 (in isoform 1) | Ubiquitination | - | 81.08 | 21890473 | |
498 (in isoform 2) | Phosphorylation | - | 55.07 | - | |
506 | Phosphorylation | PNPMVQLSIQDVTQE CCCCEEEEEEECHHH | 10.91 | 27251275 | |
507 (in isoform 2) | Ubiquitination | - | 5.72 | 21890473 | |
511 | Phosphorylation | QLSIQDVTQESKAVY EEEEEECHHHHHHHH | 34.60 | - | |
514 | Phosphorylation | IQDVTQESKAVYSTN EEECHHHHHHHHCCC | 18.98 | 27251275 | |
546 | Ubiquitination | QELDVQVKDDSRALT CCCCEEECCCHHHHH | 38.43 | 21906983 | |
546 (in isoform 1) | Ubiquitination | - | 38.43 | 21890473 | |
553 | Phosphorylation | KDDSRALTLGALTLP CCCHHHHHHHHHHHH | 23.35 | 27050516 | |
556 (in isoform 2) | Ubiquitination | - | 10.65 | 21890473 | |
580 | Phosphorylation | DQWFQLSSSGPNSRL HHHHHHCCCCCCHHH | 48.16 | - | |
588 | Phosphorylation | SGPNSRLYMKLVMRI CCCCHHHHHHHHHHH | 7.35 | - | |
626 | Phosphorylation | SENPQRGSSVDAPPR CCCCCCCCCCCCCCC | 29.40 | 23927012 | |
627 | Phosphorylation | ENPQRGSSVDAPPRP CCCCCCCCCCCCCCC | 27.17 | 23401153 | |
635 | S-palmitoylation | VDAPPRPCHTTPDSQ CCCCCCCCCCCCCHH | 4.74 | 21044946 | |
637 | Phosphorylation | APPRPCHTTPDSQFG CCCCCCCCCCCHHCC | 46.90 | 23927012 | |
637 | O-linked_Glycosylation | APPRPCHTTPDSQFG CCCCCCCCCCCHHCC | 46.90 | OGP | |
638 | Phosphorylation | PPRPCHTTPDSQFGT CCCCCCCCCCHHCCC | 11.05 | 28464451 | |
641 | Phosphorylation | PCHTTPDSQFGTEHV CCCCCCCHHCCCCCE | 28.72 | 23927012 | |
645 | Phosphorylation | TPDSQFGTEHVLRIH CCCHHCCCCCEEEEE | 24.98 | 23927012 | |
662 | Ubiquitination | EAQDLIAKDRFLGGL EHHHHHHCCCCCCHH | 42.30 | - | |
671 | Ubiquitination | RFLGGLVKGKSDPYV CCCCHHCCCCCCCCC | 66.71 | - | |
673 | Ubiquitination | LGGLVKGKSDPYVKL CCHHCCCCCCCCCEE | 46.07 | - | |
674 | Phosphorylation | GGLVKGKSDPYVKLK CHHCCCCCCCCCEEE | 53.11 | 28152594 | |
677 | Phosphorylation | VKGKSDPYVKLKLAG CCCCCCCCCEEEECC | 18.40 | 28152594 | |
679 | Acetylation | GKSDPYVKLKLAGRS CCCCCCCEEEECCCC | 33.78 | 19608861 | |
679 | Ubiquitination | GKSDPYVKLKLAGRS CCCCCCCEEEECCCC | 33.78 | 19608861 | |
679 | Malonylation | GKSDPYVKLKLAGRS CCCCCCCEEEECCCC | 33.78 | 32601280 | |
681 (in isoform 2) | Ubiquitination | - | 30.49 | - | |
681 | Ubiquitination | SDPYVKLKLAGRSFR CCCCCEEEECCCCHH | 30.49 | - | |
686 | Phosphorylation | KLKLAGRSFRSHVVR EEEECCCCHHHHCHH | 24.88 | 30266825 | |
727 | Ubiquitination | VFDKDLDKDDFLGRC EECCCCCCCCCHHCC | 67.50 | - | |
739 | Phosphorylation | GRCKVRLTTVLNSGF HCCEEEEEEEECCCC | 12.32 | 21130716 | |
740 | Phosphorylation | RCKVRLTTVLNSGFL CCEEEEEEEECCCCC | 27.82 | 21130716 | |
744 | Phosphorylation | RLTTVLNSGFLDEWL EEEEEECCCCCCCCE | 27.10 | 21130716 | |
817 | Acetylation | LPLRKGTKHLSPYAT CCCCCCCCCCCCCCE | 51.74 | 19608861 | |
817 | Ubiquitination | LPLRKGTKHLSPYAT CCCCCCCCCCCCCCE | 51.74 | 21890473 | |
817 (in isoform 1) | Ubiquitination | - | 51.74 | 21890473 | |
820 | Phosphorylation | RKGTKHLSPYATLTV CCCCCCCCCCCEEEE | 18.65 | 29255136 | |
822 | Phosphorylation | GTKHLSPYATLTVGD CCCCCCCCCEEEECC | 14.61 | 25159151 | |
824 | Phosphorylation | KHLSPYATLTVGDSS CCCCCCCEEEECCCC | 19.67 | 30266825 | |
826 | Phosphorylation | LSPYATLTVGDSSHK CCCCCEEEECCCCCC | 20.35 | 30266825 | |
827 (in isoform 2) | Ubiquitination | - | 10.11 | 21890473 | |
830 | Phosphorylation | ATLTVGDSSHKTKTI CEEEECCCCCCCCEE | 28.54 | 23927012 | |
831 | Phosphorylation | TLTVGDSSHKTKTIS EEEECCCCCCCCEEE | 33.47 | 23927012 | |
833 | Ubiquitination | TVGDSSHKTKTISQT EECCCCCCCCEEECC | 54.38 | - | |
833 | Malonylation | TVGDSSHKTKTISQT EECCCCCCCCEEECC | 54.38 | 26320211 | |
834 | Phosphorylation | VGDSSHKTKTISQTS ECCCCCCCCEEECCC | 28.17 | 20068231 | |
835 | Ubiquitination | GDSSHKTKTISQTSA CCCCCCCCEEECCCC | 48.98 | 21906983 | |
835 (in isoform 1) | Ubiquitination | - | 48.98 | 21890473 | |
836 | Phosphorylation | DSSHKTKTISQTSAP CCCCCCCEEECCCCC | 30.96 | 20068231 | |
838 | Phosphorylation | SHKTKTISQTSAPVW CCCCCEEECCCCCCC | 32.41 | 20068231 | |
840 | Phosphorylation | KTKTISQTSAPVWDE CCCEEECCCCCCCCC | 21.77 | 20068231 | |
841 | Phosphorylation | TKTISQTSAPVWDES CCEEECCCCCCCCCC | 23.96 | 20068231 | |
845 (in isoform 2) | Ubiquitination | - | 11.55 | 21890473 | |
848 | Phosphorylation | SAPVWDESASFLIRK CCCCCCCCCCEEEEC | 27.09 | 20068231 | |
850 | Phosphorylation | PVWDESASFLIRKPH CCCCCCCCEEEECCC | 29.84 | 28857561 | |
855 | Ubiquitination | SASFLIRKPHTESLE CCCEEEECCCCCCEE | 33.87 | 21906983 | |
855 (in isoform 1) | Ubiquitination | - | 33.87 | 21890473 | |
858 | Phosphorylation | FLIRKPHTESLELQV EEEECCCCCCEEEEE | 35.48 | 26471730 | |
860 | Phosphorylation | IRKPHTESLELQVRG EECCCCCCEEEEEEC | 28.44 | 20873877 | |
865 (in isoform 2) | Ubiquitination | - | 15.42 | 21890473 | |
896 | Phosphorylation | LCLDRWFTLSSGQGQ HHHCCEEECCCCCCH | 20.83 | 25850435 | |
924 | Phosphorylation | HSGVEAHSHSYSHSS CCCCCEECCCCCCCC | 22.60 | 28348404 | |
926 | Phosphorylation | GVEAHSHSYSHSSSS CCCEECCCCCCCCCC | 31.20 | 28348404 | |
927 | Phosphorylation | VEAHSHSYSHSSSSL CCEECCCCCCCCCCC | 12.65 | 28348404 | |
928 | Phosphorylation | EAHSHSYSHSSSSLS CEECCCCCCCCCCCC | 21.65 | 28348404 | |
930 | Phosphorylation | HSHSYSHSSSSLSEE ECCCCCCCCCCCCCC | 26.44 | 26657352 | |
931 | Phosphorylation | SHSYSHSSSSLSEEP CCCCCCCCCCCCCCC | 20.65 | 26657352 | |
932 | Phosphorylation | HSYSHSSSSLSEEPE CCCCCCCCCCCCCCH | 38.01 | 28348404 | |
933 | Phosphorylation | SYSHSSSSLSEEPEL CCCCCCCCCCCCCHH | 37.55 | 26657352 | |
935 | Phosphorylation | SHSSSSLSEEPELSG CCCCCCCCCCCHHHC | 41.69 | 26657352 | |
941 | Phosphorylation | LSEEPELSGGPPHIT CCCCCHHHCCCCCCC | 39.79 | 28464451 | |
948 | Phosphorylation | SGGPPHITSSAPELR HCCCCCCCCCCHHHH | 17.37 | 26657352 | |
949 | Phosphorylation | GGPPHITSSAPELRQ CCCCCCCCCCHHHHH | 24.73 | 26074081 | |
950 | Phosphorylation | GPPHITSSAPELRQR CCCCCCCCCHHHHHH | 38.91 | 26074081 | |
959 | Phosphorylation | PELRQRLTHVDSPLE HHHHHHHHCCCCCCC | 23.26 | 30266825 | |
963 | Phosphorylation | QRLTHVDSPLEAPAG HHHHCCCCCCCCCCC | 30.23 | 29255136 | |
981 | Phosphorylation | QVKLTLWYYSEERKL EEEEEEEEEECCHHH | 10.54 | - | |
982 | Phosphorylation | VKLTLWYYSEERKLV EEEEEEEEECCHHHH | 9.68 | - | |
987 | Ubiquitination | WYYSEERKLVSIVHG EEEECCHHHHHHHHH | 57.42 | - | |
997 (in isoform 2) | Ubiquitination | - | 31.79 | - | |
1009 | Phosphorylation | GRDPPDPYVSLLLLP CCCCCCCCEEEEECC | 15.28 | 21082442 | |
1011 | Phosphorylation | DPPDPYVSLLLLPDK CCCCCCEEEEECCCC | 13.88 | 25849741 | |
1011 | O-linked_Glycosylation | DPPDPYVSLLLLPDK CCCCCCEEEEECCCC | 13.88 | 23301498 | |
1018 | Ubiquitination | SLLLLPDKNRGTKRR EEEECCCCCCCCCCC | 46.75 | - | |
1022 | Phosphorylation | LPDKNRGTKRRTSQK CCCCCCCCCCCCCCC | 20.38 | - | |
1032 | Phosphorylation | RTSQKKRTLSPEFNE CCCCCCCCCCHHHHH | 40.23 | 30266825 | |
1034 | Phosphorylation | SQKKRTLSPEFNERF CCCCCCCCHHHHHHC | 23.05 | 19664994 | |
1054 | Ubiquitination | LDEAQRRKLDVSVKS CCHHHHHCCCEECCC | 51.75 | - | |
1054 | Malonylation | LDEAQRRKLDVSVKS CCHHHHHCCCEECCC | 51.75 | 26320211 | |
1058 | Phosphorylation | QRRKLDVSVKSNSSF HHHCCCEECCCCCCC | 24.40 | 20860994 | |
1060 | Ubiquitination | RKLDVSVKSNSSFMS HCCCEECCCCCCCHH | 36.09 | 2190698 | |
1060 (in isoform 1) | Ubiquitination | - | 36.09 | 21890473 | |
1061 | Phosphorylation | KLDVSVKSNSSFMSR CCCEECCCCCCCHHH | 39.53 | 23312004 | |
1063 | Phosphorylation | DVSVKSNSSFMSRER CEECCCCCCCHHHHH | 31.85 | 20044836 | |
1064 | Phosphorylation | VSVKSNSSFMSRERE EECCCCCCCHHHHHH | 29.26 | 23663014 | |
1067 | Phosphorylation | KSNSSFMSRERELLG CCCCCCHHHHHHHHC | 29.04 | 23663014 | |
1070 (in isoform 2) | Ubiquitination | - | 38.46 | 21890473 | |
1075 | Ubiquitination | RERELLGKVQLDLAE HHHHHHCCEEHHHHH | 27.12 | - | |
1083 | Phosphorylation | VQLDLAETDLSQGVA EEHHHHHCCHHHHHH | 36.31 | 29507054 | |
1093 | Phosphorylation | SQGVARWYDLMDNKD HHHHHHHHHHHCCCC | 8.14 | 28796482 | |
1099 | Ubiquitination | WYDLMDNKDKGSS-- HHHHHCCCCCCCC-- | 57.46 | - | |
1103 | Phosphorylation | MDNKDKGSS------ HCCCCCCCC------ | 38.32 | 23401153 | |
1104 | Phosphorylation | DNKDKGSS------- CCCCCCCC------- | 53.56 | 23927012 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
324 | S | Phosphorylation | Kinase | CDK5 | Q00535 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ESYT1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ESYT1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MYH10_HUMAN | MYH10 | physical | 22939629 | |
SFXN3_HUMAN | SFXN3 | physical | 22939629 | |
SYJ2B_HUMAN | SYNJ2BP | physical | 22119785 | |
ESYT2_HUMAN | ESYT2 | physical | 22119785 | |
PRAF3_HUMAN | ARL6IP5 | physical | 22119785 | |
YIF1B_HUMAN | YIF1B | physical | 22119785 | |
TMX1_HUMAN | TMX1 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-817, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1034, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-963 AND SER-1034, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-963, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-822, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-822 AND TYR-1009, ANDMASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-822 AND TYR-1009, ANDMASS SPECTROMETRY. |